In Memoriam of ProfessorRichard Scolyer

Assessing the function of tumour specific and bystander T-cells in relation to clinical outcomes of melanoma patients

Assessment of pathological features to improve accuracy of diagnosis, classification and prognosis of primary and metastatic melanoma

Clinical and histopathological correlations of melanoma in the molecular era

Clinicopathological Characterisation and Optimal Multidisciplinary Treatment of Cutaneous Head and Neck Melanoma in the Era of Effective Systemic Therapy

Defining the tumour microenvironment landscape of melanoma immunotherapy

Discovering genomic and artificial intelligence-derived biomarkers for pathological melanocytic tumour interpretation with a translational focus

Lentigo maligna diagnosis and predictors of recurrence: correlation of clinical data, dermoscopy, in vivo reflectance confocal microscopy and pathology criteria

Mechanisms of resistance to PD-1 based immunotherapy in melanoma liver metastases

Mechanisms of response and resistance to anti-PD-1 immunotherapy

Nicotinamide for skin cancer chemoprevention: effects on tumour immune cell infiltrates and melanoma biology

Reflectance confocal microscopy and Lentigo maligna management

The impacts of sequencing or combining BRAF targeted therapy with Anti-PD-1 in the neoadjuvant setting in patients with BRAF mutant melanoma

The Role of the Innate Immune System in the Treatment Response of Advanced Melanoma Patients Treated with Immunotherapy

The Use of New Non-invasive Imaging Technologies for Difficult to Diagnose Melanomas

Tumour intrinsic and immune features and their interaction in shaping melanoma progression